A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment

BACKGROUND: Haematotoxicity of conventional chemotherapies often results in delays of treatment or reduction of chemotherapy dose. To ameliorate these side-effects, patients are routinely treated with blood transfusions or haematopoietic growth factors such as erythropoietin (EPO) or granulocyte col...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirm, Sibylle, Engel, Christoph, Loeffler, Markus, Scholz, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046020/
https://www.ncbi.nlm.nih.gov/pubmed/24886056
http://dx.doi.org/10.1186/1742-4682-11-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046020/
https://www.ncbi.nlm.nih.gov/pubmed/24886056
http://dx.doi.org/10.1186/1742-4682-11-24

Ejemplares similares